Ирина Якутенко - Воля и самоконтроль - Как гены и мозг мешают нам бороться с соблазнами

84. Novak G., LeBlanc M., Zai C., Shaikh S., Renou J., DeLuca V., Bulgin N., Kennedy J. L., Le Foll B. Association of polymorphisms in the BDNF., DRD1 and DRD3 genes with tobacco smoking in schizophrenia // Annals of Human Genetics. 2010 Jul; 74 (4): 291–8.

85. Khaled M. A., Farid Araki K., Li B., Coen K. M., Marinelli P. W., Varga J., Gaál J., Le Foll B. The selective dopamine D3 receptor antagonist SB 277011-A., but not the partial agonist BP 897., blocks cue-induced reinstatement of nicotine-seeking // International Journal of Neuropsychopharmacology. 2010 Mar; 13 (2): 181–90.

86. Guillin O., Diaz J., Carroll P., Griffon N., Schwartz J. C., Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization // Nature. 2001 May 3; 411 (6833): 86–9.

87. Yang J., Wang S., Yang Z., Hodgkinson C. A., Iarikova P., Ma J. Z., Payne T. J., Goldman D., Li M. D. The contribution of rare and common variants in 30 genes to risk nicotine dependence // Molecular Psychiatry. 2015 Nov; 20 (11): 1467–78.

88. Thorgeirsson T. E. et al. A variant associated with nicotine dependence., lung cancer and peripheral arterial disease // Nature. 2008 Apr 3; 452 (7187): 638–42.

89. Brunner H. G., Nelen M., Breakefield X. O., Ropers H. H., van Oost B. A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A // Science. 1993 Oct 22; 262 (5133): 578–80.

90. Raine A. From genes to brain to antisocial behaviour // Current Directions in Psychological Science. 2008; 17:323–328.

91. Lei H., Zhang X., Di X., Rao H., Ming Q., Zhang J., Guo X., Jiang Y., Gao Y., Yi J., Zhu X., Yao S. A functional polymorphism of the MAOA gene modulates spontaneous brain activity in pons //BioMed Research International. 2014; 2014: 243280.

92. Tiihonen J., Rautiainen M. R., Ollila H. M., Repo-Tiihonen E., Virkkunen M., Palotie A., Pietiläinen O., Kristiansson K., Joukamaa M., Lauerma H., Saarela J., Tyni S., Vartiainen H., Paananen J., Goldman D., Paunio T. Genetic background of extreme violent behavior // Molecular Psychiatry. 2015Jun; 20 (6): 786–92.

93. Caspi A., McClay J., Moffitt T. E., Mill J., Martin J., Craig I. W., Taylor A., Poulton R. Role of genotype in the cycle of violence in maltreated children // Science. 2002 Aug 2; 297 (5582): 851–4.

94. van der Vegt E. J., Oostra B. A., Arias-Vásquez A., van der Ende J., Verhulst F. C., Tiemeier H.High activity of monoamine oxidase A is associated with externalizing behaviour in maltreated and nonmaltreated adoptees // Psychiatric Genetics. 2009 Aug; 19 (4): 209–11.

95. Byrd A. L., Manuck S. B. MAOA., childhood maltreatment., and antisocial behavior: meta-analysis of a gene-environment interaction // Biological Psychiatry. 2014 Jan 1;75 (1): 9–17.

96. Ouellet-Morin I., Côté S. M., Vitaro F., Hébert M., Carbonneau R., Lacourse É., Turecki G., Tremblay R. E. Effects of the MAOA gene and levels of exposure to violence on antisocial outcomes //British Journal of Psychiatry. 2016 Jan; 208 (1): 42–8.

97. McDermott R., Tingley D., Cowden J., Frazzetto G., D. P. Johnson D. Monoamine oxidase A gene (MAOA) predicts behavioral aggression following provocation // Proceedings of the National Academy of Sciences of the United States of America. 2009 Feb 17; 106 (7): 2118–2123.

98. Crockett M. J., Clark L., Tabibnia G., Lieberman M. D., Robbins T. W. Serotonin modulates behavioral reactions to unfairness // Science. 2008 Jun 27; 320 (5884): 1739.

99. van Donkelaar E. L., Blokland A., Ferrington L., Kelly P. A., Steinbusch H. W., Prickaerts J. Mechanism of acute tryptophan depletion: is it only serotonin? // Molecular Psychiatry. 2011 Jul; 16 (7): 695–713.

100. Bondy B., Erfurth A., de Jonge S., Krüger M., Meyer H. Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide // Molecular Psychiatry. 2000 Mar; 5 (2): 193–5.

101. Носкова Т. Г. и др. Роль гена переносчика серотонина в развитии униполярной депрессии // Материалы Международной конференции "Генетика в России и мире", посвященной 40-летию Института общей генетики им. Н. И. Вавилова РАН, Москва, 28 июня – 2 июля., 2006. М., 2006. С. 142.

102. Hariri A. R., Mattay V. S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M. F., Weinberger D. R. Serotonin transporter genetic variation and the response of the human amygdala //Science. 2002 Jul 19; 297 (5580): 400–3.

103. Kobiella A., Reimold M., Ulshöfer D. E., Ikonomidou V. N., Vollmert C., Vollstädt-Klein S., Rietschel M., Reischl G., Heinz A., Smolka M. N. How the serotonin transporter 5-HTTLPR polymorphism influences amygdala function: the roles of in vivo serotonin transporter expression and amygdala structure // Translational Psychiatry. 2011 Aug 30; 1: e37.

104. Gallinat J., Bauer M., Heinz A. Genes and neuroimaging: advances in psychiatric research //Neurodegenerative Diseases. 2008; 5 (5): 277–85.

105. Jasinska A. J., Lowry C. A., Burmeister M. Serotonin transporter gene., stress and raphe-raphe interactions: a molecular mechanism of depression // Trends in Neuroscience. 2012 Jul; 35 (7): 395–402.

106. Петровский Е. Д., Савостьянов А. Н. и др. Влияние полиморфизма аллелей серотонинового транспортера на индивидуальные особенности мозговой гемодинамики у людей в условиях экспериментальной парадигмы "стоп-сигнал" // Вавиловский журнал генетики и селекции. 2014. Т. 18. № 4/3: 1281–8.

107. Slof-Op't Landt M. C., Bartels M., Middeldorp C. M., van Beijsterveldt C. E., Slagboom P. E., Boomsma D. I., van Furth E. F., Meulenbelt I. Genetic variation at the TPH2 gene influences impulsivity in addition to eating disorders // Behavior Genetics. 2013 Jan; 43 (1): 24–33.

108. Chung I. W., Kim H., Sribney W., Hong J. B., Lee C. H., Lee K. Y., Nan H. M., Kim Y. S., Manowitz P. Tryptophan hydroxylase polymorphism is associated with age of onset of alcoholism related behaviors // Alcohol. 2005 May; 36 (1): 1–3.

109. Ruocco A. C., Rodrigo A. H., Carcone D., McMain S., Jacobs G., Kennedy J. L. Tryptophan hydroxylase 1 gene polymorphisms alter prefrontal cortex activation during response inhibition //Neuropsychology. 2016 Jan; 30 (1): 18–27.

110. Preuss N., Salehi B., van der Veen J. W., Shen J., Drevets W. C., Hodgkinson C., Goldman D., Hasler G. Associations between prefrontal γ-aminobutyric acid concentration and the tryptophan hydroxylase isoform 2 gene., a panic disorder risk allele in women // International Journal of Neuropsychopharmacology. 2013 Sep; 16 (8): 1707–17.

111. Harris A. D., Singer H. S., Horska A., Kline T., Ryan M., Edden R. A., Mahone E. M. GABA and Glutamate in Children with Primary Complex Motor Stereotypies: An 1H-MRS Study at 7T //American Journal of Neuroradiology. 2016 Mar; 37 (3): 552–7.

112. Silveri M. M., Sneider J. T., Crowley D. J., Covell M. J., Acharya D., Rosso I. M., Jensen J. E.Frontal lobe γ-aminobutyric acid levels during adolescence: associations with impulsivity and response inhibition // Biological Psychiatry. 2013 Aug 15; 74 (4): 296–304.

113. Lee R., Petty F., Coccaro E. F. Cerebrospinal fluid GABA concentration: relationship with impulsivity and history of suicidal behavior., but not aggression., in human subjects // Journal of Psychiatric Research. 2009 Jan; 43 (4): 353–9.

114. Boy F., Evans C. J., Edden R. A., Lawrence A. D., Singh K. D., Husain M., Sumner P. Dorsolateral prefrontal γ-aminobutyric acid in men predicts individual differences in rash impulsivity //Biological Psychiatry. 2011 Nov 1; 70 (9): 866–72.